Filter
481
Text search:
cognitive
behavioural
therapy
Featured
51
93
Language
Document type
358
50
32
23
8
4
3
2
1
Countries / Regions
24
16
12
9
8
7
7
7
7
5
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
89
37
32
29
6
5
1
Toolboxes
239
39
26
14
11
8
6
6
4
4
4
3
2
2
2
1
1
World Drug Report 2017
-1-
Accessed: 14.03.2019
Petersen et al. Int J Ment Health Syst (2016) 10:30 DOI 10.1186/s13033-016-0060-z
A new frontier for integrated care.
Until now, most efforts to promote integrated care have focused on bridging the gaps between health and social care or between primary and secondary care. But the NHS five year forward view has highlighted a third dimension – bringing together physical and ment
...
This module should always be used together with the
mhGAP Intervention Guide for Mental, Neurological
and Substance Use Disorders in Non-specialized Health
Settings (WHO, 2010), which outlines relevant general
principles of care and management of a range of other
mental, neurological and substa
...
Assessment of the quality of institutional care for adults with psychosocial and intellectual disabilities in the WHO European Region.
The specific objectives of the project were to address gaps in knowledge about the number and characteristics of such long-term institutions and to identify deficie
...
Depression is a leading cause of non-fatal disease burden worldwide, with a lifetime prevalence of 9% among European adult men and 17% among European adult women.
The task at hand requires substantial investments in preventive mental health care, but the potential benefits can be equally rewarding.
...
WHO mhGAP Guideline update
recommended
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
Introduction
Chapter A.7
Other disorders
Chapter H.6
Целью этой главы является представление ключевых элементов, касающихся терапевтического использования психотропных лекарственных средств у детей и подростков,
...
Introducción
Capítulo A.7
Edición en español
Editor: Juan José García-Orozco
Traducción: Juan José García-Orozco y Carlos González Vivas
Revisor de traducción: Laura Borredá Belda
Trastornos de ansiedad
Capítulo F.1
Edición en español
Editor: Matías Irarrázaval
Traducción: Matías Irarrázaval y María Tatiana Estefan
Trastornos de ansiedad
Capítulo F.2
Versión en español:
Editor: Cesar Soutullo
Traductores: Andrea Candelas-Muñoz, Cecilia Hernández-González, Ana Mena
Otros desórdenes
Capítulo H.6
Editor: Laura Revert Marín, Matías Irarrázaval & Andres Martin
Traducción: Silvia Rodriguez Portillo, Alfonso Pastor Romero y Paula Cox
Q 12: In children and adolescents with anxiety disorders, what is the effectiveness and safety, considering system issues in low- and middle-income countries, of using pharmacological interventions in non-specialist settings?
(2015)
Scoping question: Are antidepressants (specifically, tricyclic antidepressants and selective serotonin reuptake inhibitors) effective and safe in adolescents with moderate-severe depressive disorder for whom psychosocial interventions have proven ineffective?
Troubles anxieux
Chapitre F.1
Edition en français Traduction : Jean-Philippe Raynaud Avec le soutien de la SFPEADA
Autres troubles
Chapitre H.6
Edition en français Traduction : Basile Gonzales Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA
Providing community-based mental health services position paper
